Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+8.9%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$7.67B
AUM Growth
+$1.53B
(+25%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
20.43%
Holding
1,048
New
63
Increased
792
Reduced
112
Closed
32
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$28.6M |
| 2 |
RTX Corp
RTX
|
$24.7M |
| 3 |
Apple
AAPL
|
$24.4M |
| 4 |
Procter & Gamble
PG
|
$22M |
| 5 |
Walt Disney
DIS
|
$21.6M |
Top Sells
| 1 |
iShares MSCI Saudi Arabia ETF
KSA
|
$21.6M |
| 2 |
Lamb Weston
LW
|
$14.9M |
| 3 |
3M
MMM
|
$12.9M |
| 4 |
CELG
Celgene Corp
CELG
|
$12.2M |
| 5 |
MSCI
MSCI
|
$10M |
Sector Composition
| 1 | Technology | 19.32% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 12.78% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHCT
901
Community Healthcare Trust
CHCT
$444M
| $166K | ﹤0.01% |
3,879
+405
| +12% | +$17.3K |
|
902
Editas Medicine
EDIT
$248M
| $165K | ﹤0.01% |
5,684
-670
| -11% | -$19.4K |
|
903
Ultragenyx Pharmaceutical
RARE
$3.07B
| $165K | ﹤0.01% |
3,839
+1,309
| +52% | +$56.3K |
|
|
CIO
904
City Office REIT
CIO
$280M
| $164K | ﹤0.01% |
12,273
+4,000
| +48% | +$53.5K |
|
905
Standex International
SXI
$2.52B
| $163K | ﹤0.01% |
2,068
-1,299
| -39% | -$102K |
|
906
Atara Biotherapeutics
ATRA
$90.7M
| $162K | ﹤0.01% |
404
+171
| +73% | +$68.6K |
|
|
CSR
907
Centerspace
CSR
$1.01B
| $162K | ﹤0.01% |
2,281
| – | – |
|
908
Iovance Biotherapeutics
IOVA
$901M
| $161K | ﹤0.01% |
6,307
-2,574
| -29% | -$65.7K |
|
909
Codexis
CDXS
$218M
| $159K | ﹤0.01% |
9,643
+2,092
| +28% | +$34.5K |
|
910
Krystal Biotech
KRYS
$4.35B
| $157K | ﹤0.01% |
+2,639
| New | +$157K |
|
|
AEGN
911
DELISTED
Aegion Corp
AEGN
| $154K | ﹤0.01% |
6,878
-2,814
| -29% | -$63K |
|
|
ALX
912
Alexander's
ALX
$1.2B
| $153K | ﹤0.01% |
460
+81
| +21% | +$26.9K |
|
913
HDFC Bank
HDB
$361B
| $153K | ﹤0.01% |
2,464
-86
| -3% | -$5.34K |
|
|
UBA
914
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $149K | ﹤0.01% |
6,166
-136
| -2% | -$3.29K |
|
915
Precigen
PGEN
$1.3B
| $148K | ﹤0.01% |
24,815
-5,716
| -19% | -$34.1K |
|
916
Regenxbio
RGNX
$490M
| $147K | ﹤0.01% |
3,763
+271
| +8% | +$10.6K |
|
917
WaFd
WAFD
$2.5B
| $144K | ﹤0.01% |
3,960
| – | – |
|
918
Workhorse Group
WKHS
$19.4M
| $143K | ﹤0.01% |
+186
| New | +$143K |
|
|
TNAV
919
DELISTED
Telenav Inc.
TNAV
| $143K | ﹤0.01% |
29,347
+22,013
| +300% | +$107K |
|
|
RESI
920
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $142K | ﹤0.01% |
11,233
+2,303
| +26% | +$29.1K |
|
921
Voyager Therapeutics
VYGR
$235M
| $141K | ﹤0.01% |
10,520
+4,264
| +68% | +$57.2K |
|
|
WPG
922
DELISTED
Washington Prime Group Inc.
WPG
| $140K | ﹤0.01% |
4,483
+485
| +12% | +$15.1K |
|
923
Intellia Therapeutics
NTLA
$1.29B
| $139K | ﹤0.01% |
9,510
-43
| -0.5% | -$628 |
|
924
Alaunos Therapeutics
TCRT
$4.27M
| $139K | ﹤0.01% |
207
-18
| -8% | -$12.1K |
|
|
BFS
925
Saul Centers
BFS
$812M
| $138K | ﹤0.01% |
2,632
+492
| +23% | +$25.8K |
|